Hiroyuki Mori

ORCID: 0000-0002-0043-0639 · 7 papers in corpus · active 1998-2007

Study types

  • article 7

Condition tags

  • endometriosis 6
article 2007
P1-IS-105 New strategy for medical treatment of endometriosis :
article 2006
P-355
·doi:10.1016/j.fertnstert.2006.07.711
article 2002
Effect of alendronate and menatetrenone administration on bone formation during Gn-RH agonist treatment for endometriosis
·doi:10.1016/s0015-0282(02)04098-0
article 2001
CA-125 dynamic test: a novel method for clinical diagnosis of endometriosis.
·doi:10.1016/s0015-0282(01)02435-9
article 2000
Effectiveness of long term GN‐RH agonist administration for treatment of endometriosis combined with estrogen‐progestogen add back therapy
·doi:10.1016/s0020-7292(00)82576-x
article 1999
Rates of Endometriosis Recurrence and Pregnancy 1 Year after Treatment with Intranasal Buserelin Acetate (Suprecur®) (A Prospective Study)
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.1999.tb01141.x

OBJECTIVES: This multicenter prospective study of buserelin acetate (Suprecur) therapy for endometriosis was performed in order to examine pregnancy rates and the recurrence of endometriosis 1 year after the end of intranasal administration…

article 1998
Suppression of macrophage activation by peritoneal fluid from patients with endometriosis
FEMS immunology and medical microbiology ·doi:10.1111/j.1574-695x.1998.tb01133.x

To investigate the effects of peritoneal fluid from patients with endometriosis on mouse peritoneal macrophages (Mphi), peritoneal fluid from endometriosis patients (n = 15) were added to a monolayer of C3H/HeJ mouse peritoneal Mphi. Tumor …